Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 March 2026.Powered by Capital Market - Live News

Net loss of Beryl Drugs reported to Rs 0.17 crore in the quarter ended December 2025 as against net profit of Rs 0.05 crore during the previous quarter ended December 2024. Sales declined 28.81% to Rs 3.78 crore in the quarter ended December 2025 as against Rs 5.31 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.785.31 -29 OPM %-5.2910.92 - PBDT-0.290.46 PL PBT-0.610.15 PL NP-0.170.05 PL Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 January 2026.Powered by Capital Market - Live News

Net profit of Beryl Drugs remain constant at Rs 0.01 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 8.73% to Rs 5.12 crore in the quarter ended September 2025 as against Rs 5.61 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales5.125.61 -9 OPM %14.269.98 - PBDT0.650.44 48 PBT0.260.11 136 NP0.010.01 0 Powered by Capital Market - Live News